Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genetix licenses reagent for genetic mutations:

This article was originally published in Clinica

Executive Summary

UK company Genetix Group has licensed a DNA-based reagent, to detect genetic mutations linked to hereditary diseases, from the University of Nottingham. The New Milton, Hampshire company plans to manufacture and market the reagent as part of its consumables range. It can be used with Genetix' automated systems. It will allow clinical researchers to determine more effectively the nature of mutations in conditions such as breast cancer.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts